Shankar Vallabhajosula

Phase I Trial of ¹⁷⁷Lutetium-Labeled J591, a Monoclonal Antibody to Prostate-Specific Membrane Antigen, in Patients With Androgen-Independent Prostate Cancer

Neil H. Bander, Matthew I. Milowsky, David M. Nanus et al. · Journal of Clinical Oncology · 2005 · 508 citations

Medicine, Oncology, Pharmacokinetics +17

Phase II Study of Lutetium-177–Labeled Anti-Prostate-Specific Membrane Antigen Monoclonal Antibody J591 for Metastatic Castration-Resistant Prostate Cancer

Scott T. Tagawa, Matthew I. Milowsky, Michael J. Morris et al. · Clinical Cancer Research · 2013 · 426 citations · Full text

Medicine, Nuclear Medicine, Oncology +17

Phase I Trial of Yttrium-90—Labeled Anti—Prostate-Specific Membrane Antigen Monoclonal Antibody J591 for Androgen-Independent Prostate Cancer

Matthew I. Milowsky, David M. Nanus, Lale Kostakoğlu et al. · Journal of Clinical Oncology · 2004 · 313 citations · Full text

Medicine, Oncology, Pharmacokinetics +17

Sex differences in Alzheimer risk

Lisa Mosconi, Valentina Berti, Crystal Quinn et al. · Neurology · 2017 · 312 citations · Full text

Medicine, Neurology, Neuroscience +17

Selective CDK4/6 inhibition with tumor responses by PD0332991 in patients with mantle cell lymphoma

John P. Leonard, Ann S. LaCasce, Mitchell R. Smith et al. · Blood · 2012 · 297 citations · Full text

Medicine, Oncology, Pharmacology +14